A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -68.26%. However, over the past six months, we’ve seen a stronger performance of -58.71%. The price of SXTC leaped by -37.07% over the last 30 days. And in the last five days, it has fallen by -11.64%.
China SXT Pharmaceuticals Inc’s stock market performance has been somewhat irregular.
52-week price history of SXTC Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. China SXT Pharmaceuticals Inc’s current trading price is -89.18% away from its 52-week high, while its distance from the 52-week low is 35.79%. The stock’s price range for this period has been between $0.95 and $11.92. The Healthcare sector company’s shares saw a trading volume of about 5.59 million for the day, which was higher than the average daily volume of 4.12 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
China SXT Pharmaceuticals Inc (SXTC) has experienced a quarterly decline of -76.71% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 33.58M and boasts a workforce of 75 employees.
How Moving Averages and Trading Volume Data Work Together
SXTC’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for SXTC stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.02.
